MELI vs OGEN · P/E 43, rev $20.78B vs rev $37.7K
MercadoLibre Inc. (MELI) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported MELI revenue for 2024-12-31 was $20.78B. Net income was $1.91B. Revenue was up 387.6% from 2023-12-31 to 2024-12-31. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
MELI currently screens at market cap $82.73B and trailing P/E 43.1. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the MELI and OGEN stock pages for the full models.
Not investment advice.